Topical TLR7 agonist and radiotherapy in patients with metastatic breast cancer

Topical TLR7 agonist and radiotherapy in patients with metastatic breast cancer

Background Toll-like receptor (TLR) agonists and radiation therapy hold promise for cancer immunotherapy. We conducted a phase I/II trial combining topical imiquimod (IMQ, a TLR-7 agonist) and local radiotherapy (RT) in patients with metastatic breast cancer accompanied by longitudinal transcription...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ping Jin, Xiaochun Li, Francesco Marincola, Ena Wang, Sandra Demaria, Davide Bedognetti, Darawan Rinchai, Sylvia Adams, Yelena Novik, Ruth Oratz, David Stroncek, Judith Goldberg, Silvia Chiara Formenti, Maria Fenton-Kerimian, Pascale G Levine
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-04-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/13/4/e011173.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Enhancing antitumor immunity through the combination of cholesterolized TLR7 agonist liposomes and radiotherapy: a role for IL‐1β and the inflammasome pathway
by: Xuejiao Han, et al.
Published: (2025-07-01)

TLR4 Agonist Monophosphoryl Lipid A Alleviated Radiation-Induced Intestinal Injury
by: Jiaming Guo, et al.
Published: (2019-01-01)

Single atom engineering for radiotherapy-activated immune agonist prodrugs
by: Zexuan Ding, et al.
Published: (2025-07-01)

TLR4 Agonist and Hypoxia Synergistically Promote the Formation of TLR4/NF-κB/HIF-1α Loop in Human Epithelial Ovarian Cancer
by: Bin Zhao, et al.
Published: (2022-01-01)

Multivalent COBRA Hemagglutinin and Neuraminidase Influenza Vaccines Adjuvanted with TLR9 Agonist CpG 1018
by: Pedro L. Sanchez, et al.
Published: (2025-06-01)

HIV envelope antibodies and TLR7 agonist partially prevent viral rebound in chronically SHIV-infected monkeys.
by: Brian Moldt, et al.
Published: (2022-04-01)

Self-assembling TLR2 agonists promote mucosal immune responses without pulmonary immunopathologic injuries in mice
by: Zhangping Huang, et al.
Published: (2025-06-01)

Gut microbiota-derived GlcNAc-MurNAc is a TLR4 agonist that protects the host gut
by: Chenyu Li, et al.
Published: (2025-07-01)

The TLR7/8 agonist INI-4001 enhances the immunogenicity of a Powassan virus-like-particle vaccine
by: Michael W. Crawford, et al.
Published: (2025-07-01)

Novel adjuvant delivery system constructed by alum-emulsion hybrid nanoparticles with TLR9 agonists boosts vaccine immunity
by: Yarong Zeng, et al.
Published: (2025-07-01)

Enhancing radiotherapy-induced anti-tumor immunity via nanoparticle-mediated STING agonist synergy
by: Qian Zeng, et al.
Published: (2025-06-01)

TLR3 Agonist Amplifies the Anti-Inflammatory Potency of ADSCs via IL-10-Mediated Macrophage Polarization in Acute Pancreatitis
by: Jianxing Liu, et al.
Published: (2024-01-01)

Adjuvantation of Kyasanur Forest Disease vaccine with TLR9 agonist CpG adjuvant enhances immunological efficacy and potency of the vaccine
by: Chandranaik B. Marinaik, et al.
Published: (2025-01-01)

Adjuvantation of Kyasanur Forest Disease vaccine with TLR9 agonist CpG adjuvant enhances immunological efficacy and potency of the vaccine.
by: Chandranaik B Marinaik, et al.
Published: (2025-01-01)

Non-blocking anti-PD-L1 nanobody conjugated to TLR7 agonist mediates macrophage/NK cell-associated antitumor effects
by: Chao Hu, et al.
Published: (2025-07-01)

C3-Liposome Delivery of MUC1 Peptide and TLR Agonists Enhances Adaptive Immunity and Results in Sex-Based Tumor Growth Differences
by: Shahab Soltani, et al.
Published: (2025-04-01)

Orchestrating intratumoral DC-T cell immunity for enhanced tumor control via radiotherapy-activated TLR7/8 prodrugs in mice
by: Xiaozhe Yin, et al.
Published: (2025-07-01)

Protein Expression of TLR2, TLR4, and TLR9 on Monocytes in TB, HIV, and TB/HIV
by: Wegene Tamene, et al.
Published: (2024-01-01)

Nonbilayer Phospholipid Arrangements Are Toll-Like Receptor-2/6 and TLR-4 Agonists and Trigger Inflammation in a Mouse Model Resembling Human Lupus
by: Carlos Wong-Baeza, et al.
Published: (2015-01-01)

A TLR9 agonist synergistically enhances protective immunity induced by an Alum-adjuvanted H7N9 inactivated whole-virion vaccine
by: Tsai-Teng Tzeng, et al.
Published: (2023-12-01)

Eicosanoids in the Innate Immune Response: TLR and Non-TLR Routes
by: Yolanda Alvarez, et al.
Published: (2010-01-01)

Single nucleotide polymorphisms of TLR-2, TLR-3, TLR-4 and susceptibility to inflammatory diseases of the respiratory tract
by: N. O. Pryimenko, et al.
Published: (2018-10-01)

TLR2 and TLR4 bridge physiological and pathological inflammation in the reproductive system
by: Alireza Mansouri, et al.
Published: (2025-07-01)

Hyperexpression of TLR2 and TLR4 in patients with ischemic stroke in acute period of the disease
by: L. V. Gankovskaya, et al.
Published: (2020-08-01)

RISK FOR PNEUMONIA AND TLR2 AND TLR4 GENE POLYMORPHISMS: A META-ANALYSIS
by: S. V. Smirnova, et al.
Published: (2016-01-01)

ASSOCIATION OF TLR2, TLR4, TLR9 GENE EXPRESSION RELATED TO INNATE IMMUNITY WITH IN VIVO ACUTE RESPIRATORY INFECTIONS CAUSED BY KLEBSIELLA PNEUMONIAE
by: E. V. Budanova, et al.
Published: (2018-06-01)

Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumors
by: Douglas E Feltner, et al.
Published: (2025-07-01)

TLR4 and Insulin Resistance
by: Jane J. Kim, et al.
Published: (2010-01-01)

Effect of Helicobacter pylori Eradication on TLR2 and TLR4 Expression in Patients with Gastric Lesions
by: Aline Cristina Targa Cadamuro, et al.
Published: (2015-01-01)

Innate immune response to Streptococcus pyogenes depends on the combined activation of TLR13 and TLR2.
by: Christina Fieber, et al.
Published: (2015-01-01)

Impaired Surface Expression of HLA-DR, TLR2, TLR4, and TLR9 in Ex Vivo-In Vitro Stimulated Monocytes from Severely Injured Trauma Patients
by: David Heftrig, et al.
Published: (2017-01-01)

Both TLR2 and TRIF contribute to interferon-β production during Listeria infection.
by: Camille Aubry, et al.
Published: (2012-01-01)

Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial
by: Lucia Bailón, et al.
Published: (2025-03-01)

ASSOCIATION STUDIES BETWEEN POLYMORPHIC MARKERS TLR2 AND TLR9, PRE-TERM DELIVERY AND INTRAUTERINE INFECTIONS
by: O. .A. Gankovskaya
Published: (2014-07-01)

The expression of genes TLR2 and TLR10 in the gastric tissue of patients with gastroduodenal disorders caused by Helicobacter pylori
by: Samara Kadhim Mohammed, et al.
Published: (2024-08-01)

Biological sex representation and reporting in stereotactic body radiotherapy for kidney cancer: A review of clinical studies
by: Sylvia Nwokolo, et al.
Published: (2025-11-01)

ROLE OF TLR2, TLR4 GENE POLYMORPHISM IN DEVELOPING MICROVASCULAR COMPLICATIONS IN ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
by: A. A. Voropai, et al.
Published: (2021-10-01)

Polymorphisms of TLR1, TLR4 and SLC11A1 Genes in Some Cattle Breeds Reared in Turkey
by: Korhan Arslan
Published: (2018-12-01)

Prognostic significance of <I>TLR3</I> and <I>TLR9</I> gene polymorphism in assessing the severity of COVID-19
by: L. A. Ashchina, et al.
Published: (2024-04-01)

TLR3, TLR4 and TLRs7-9 Induced Interferons Are Not Impaired in Airway and Blood Cells in Well Controlled Asthma.
by: Annemarie Sykes, et al.
Published: (2013-01-01)